LIVN News and Press, LivaNova PLC From 10/04/21

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its third quarter 2021 results on Wednesday, November 3, 2021 at 12 p.m. London time (8 a.m. Eastern Daylight Time). The Company will release its third quarter ...

Harris Associates’ 13F portfolio value increased from $58.52B to $62.80B this quarter. They increased Fiserv, Netflix, Regeneron, and Alibaba while decreasing Cenovus Energy, Mastercard, Howmet Aerospace, Caterpillar, and MGM Resorts. The top three positions are Alphabet, B...

With 62 recent IPOs becoming part of The Russell 2000 small-cap index following its Q3 recalibrations, we highlight the healthcare stocks among the new entrants. The below discussion is a follow-up to the previous article on newly IPO’d healthcare constituents in the Index. R...

NEWTOWN, Pa., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the appointment of Paul Buckman to its Board of Directors, effectiv...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present at the Baird 2021 Global Healthcare Conference on Wednesday, September 15 at 9:40 a.m. Eastern Time. The discussion will be ...

Special situation of a business opportunity suddenly coming back to life with no one noticing. Compelling situation in valuable markets from an insurance pickup perspective, meaning a business option is afoot. Based on the SoTP valuation of the business, seems like you get the dep...

Announcement follows closing of underwritten offering of ordinary shares LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced the early retirement of its $450 million five-year senior secured term loan (the Term Loan). T...

LivaNova (NASDAQ:LIVN) has priced its public offering of 3,636,364 ordinary shares at $82.50/share. Underwriters' over-allotment is an additional 545,454 shares. Expected net proceeds of ~$280.1M will be used to partially fund the repayment of its existing $450M five-year senior secured term ...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced that it has priced an underwritten offering of 3,636,364 ordinary shares at a price to the public of $82.50 per share. The Company also granted the underwriters a 30-day option to acq...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has commenced an underwritten offering of $300 million of its ordinary shares. LivaNova also intends to grant the underwriters of the offering a 30-day option to acquire up to an a...